Our Mission

At Asyst Therapeutics, we develop next-generation treatments for polycystic kidney and liver disease (PKD/PLD)—targeting the root cause of cyst formation to create true disease-modifying therapies.

Our Founders

Dr. Sorin Fedeles
Expert in genetics and biomedical research, Dr. Fedeles has spent years pioneering PKD research at Yale University, developing breakthrough discoveries that shape our therapies today.

Dr. Matteus Krappitz
A leader in nephrology and targeted therapy development, Dr. Krappitz is dedicated to translating cutting-edge science into real-world treatments that will change the standard of care for PKD patients.